HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

anthranilamide

Also Known As:

2-aminobenzamide; ortho-aminobenzamide

Networked: 14 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzoates: 426
        Aminobenzoates: 1
        ortho-Aminobenzoates: 8
        anthranilamide: 14
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Benzoates: 426
      - Aminobenzoates: 1
        ortho-Aminobenzoates: 8
        anthranilamide: 14

Experts

1.	Gottesfeld, Joel M: 3 articles (01/2015 - 09/2012)
2.	Rusche, James R: 2 articles (01/2015 - 09/2012)
3.	Soragni, Elisabetta: 2 articles (01/2015 - 09/2012)
4.	Xu, Chunping: 2 articles (11/2014 - 09/2012)
5.	Kamal, Ahmed: 2 articles (10/2013 - 08/2012)
6.	Pal-Bhadra, Manika: 2 articles (10/2013 - 08/2012)
7.	Ramaiah, M Janaki: 2 articles (10/2013 - 08/2012)
8.	Tamboli, Jaki R: 2 articles (10/2013 - 08/2012)
9.	Cai, Jin: 1 article (01/2015)
10.	Cao, Meng: 1 article (01/2015)

Related Diseases

1.	Friedreich Ataxia (Friedreich's Ataxia) 01/01/2015 - "Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich's Ataxia." 11/07/2014 - "Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich's ataxia patient iPSC-derived neural stem cells." 09/01/2012 - "Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia." 11/07/2014 - "Members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics for the neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's disease (HD). "
2.	Neoplasms (Cancer) 08/01/2007 - "SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer." 06/01/2006 - "New series histone deacetylase inhibitors comprising a hydroxamic acid or 2-aminobenzamide group as a zinc-chelating function were synthesized and evaluated for antiproliferative activities against a panel of human cancer cells. "
3.	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/15/2013 - "It has previously been shown that anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates activate p53 and cause apoptosis in cervical cancer cells such as HeLa and SiHa. " 08/01/2012 - "A library of new anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates were designed, synthesized, and evaluated for their anticancer activity in cervical cancer cells such as HeLa and SiHa that possess low levels of p53. " 08/01/2012 - "Anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates as p53 activators in cervical cancer cells."
4.	Carcinoma (Carcinomatosis) 08/01/2013 - "A new series of anthranilamide derivatives were synthesized and evaluated for their antiproliferative activities against human colon carcinoma cell lines (HCT 116) and human breast adenocarcinoma cell lines (MDA-MB-231) in vitro. " 01/01/2013 - "Here, protein glycosylation of exosomes from ovarian carcinoma SKOV3 cells has been studied by lectin blotting, NP-HPLC analysis of 2-aminobenzamide labeled glycans and mass spectrometry. "
5.	Neurodegenerative Diseases (Neurodegenerative Disease) 11/07/2014 - "Members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics for the neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's disease (HD). "

Related Drugs and Biologics

1.	Histone Deacetylase Inhibitors
2.	Polysaccharides (Glycans)
3.	pyrimidine
4.	Uromodulin
5.	Protein Kinase Inhibitors
6.	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
7.	Lectins
8.	Zinc
9.	Hydroxamic Acids (Hydroxamic Acid)
10.	Histone Deacetylases (Histone Deacetylase)

Related Therapies and Procedures

1.	Therapeutics